Maze Therapeutics, Inc. · NASDAQ:MAZE

Coloma Jason V sold 34,501 Maze Therapeutics, Inc. shares (Form 4)

Traded Sep 1, 2026 · Filed Sep 3, 2026

On Sep 1, 2026, Coloma Jason V (Director, Chief Executive Officer) sold 34,501 Maze Therapeutics, Inc. shares at an average US$26.29 for US$907K under a trading plan, leaving 50,000 shares. Filed Sep 3, 2026 (Form 4).

Sold
34,501 shares
Price
US$26.29 average (US$26.29 to US$26.31)
Value
US$907K
Holding after
50,000 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 1, 2026Common StockSale2,593US$26.3118,151Indirect
Sep 1, 2026Common StockSale31,908US$26.29223,355Indirect
Sep 1, 2026Common StockOption exercise50,00050,000Direct

Source

View original at SEC

Related